Covered recipient · General Payments record
ELVANA MUKA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,470.15
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $747.00 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $335.59 | 16 |
| Abbott Laboratories | $144.13 | 1 |
| Novo Nordisk AS | $133.10 | 3 |
| Otsuka America Pharmaceutical, Inc. | $36.28 | 2 |
| PFIZER INC. | $24.48 | 1 |
| ITI, Inc. | $22.64 | 1 |
| Lilly USA, LLC | $18.75 | 1 |
| Janssen Pharmaceuticals, Inc | $16.48 | 1 |
| Corium, Inc. | $15.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $144.13 | 05/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125352736 | CMS |
| ABBVIE INC. | $14.66 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704234 | CMS |
| ABBVIE INC. | $13.67 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704236 | CMS |
| ABBVIE INC. | $101.80 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704238 | CMS |
| ABBVIE INC. | $14.31 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704240 | CMS |
| ABBVIE INC. | $34.96 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704242 | CMS |
| ABBVIE INC. | $6.44 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704244 | CMS |
| ABBVIE INC. | $16.34 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704246 | CMS |
| ABBVIE INC. | $10.33 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704248 | CMS |
| ABBVIE INC. | $28.77 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704250 | CMS |
| ABBVIE INC. | $6.50 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704252 | CMS |
| ABBVIE INC. | $11.26 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704254 | CMS |
| ABBVIE INC. | $17.33 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704256 | CMS |
| ABBVIE INC. | $6.55 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704258 | CMS |
| ABBVIE INC. | $13.49 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704260 | CMS |
| ABBVIE INC. | $27.25 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704262 | CMS |
| ABBVIE INC. | $11.93 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107704264 | CMS |
| Corium, LLC | $15.55 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100111396 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22.64 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143562716 | CMS |
| Janssen Pharmaceuticals, Inc | $16.48 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078132441 | CMS |
| Lilly USA, LLC | $18.75 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135629119 | CMS |
| Novo Nordisk Inc | $16.60 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100313821 | CMS |
| Novo Nordisk Inc | $15.39 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100350790 | CMS |
| Novo Nordisk Inc | $101.11 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100367351 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.43 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119145357 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.85 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119145359 | CMS |
| PFIZER INC. | $24.48 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132014542 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.